Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

CO2-Independent Growth Medium for Maintenance and Propagation of Cells

  • Read more about CO2-Independent Growth Medium for Maintenance and Propagation of Cells
Patent Cooperation Treaty
PCT/US91/000451
Filed on 1991-01-22

HLA-A2 and HLA-DR Specific Peptide Epitopes From the Melanoma Antigen TRP-2

  • Read more about HLA-A2 and HLA-DR Specific Peptide Epitopes From the Melanoma Antigen TRP-2
Patent Cooperation Treaty
PCT/US1999/024887
Filed on 1999-10-22

RECOMBINANT INFLUENZA VIRUSES EXPRESSING TUMOR-ASSOCIATED ANTIGENS AS ANTITUMOR AGENTS

  • Read more about RECOMBINANT INFLUENZA VIRUSES EXPRESSING TUMOR-ASSOCIATED ANTIGENS AS ANTITUMOR AGENTS
US Patent 6,884,414
Filed on 1998-04-30

RECOMBINANT INFLUENZA VIRUSES EXPRESSING TUMOR-ASSOCIATED ANTIGENS AS ANTITUMOR AGENTS

  • Read more about RECOMBINANT INFLUENZA VIRUSES EXPRESSING TUMOR-ASSOCIATED ANTIGENS AS ANTITUMOR AGENTS
Patent Cooperation Treaty
PCT/US98/008929
Filed on 1998-04-30

Method of Reversing Chemotherapeutic Drug Resistance in Tumor or Cancer Cells Utitlizing an Acidically-Modified Dominant Negative

  • Read more about Method of Reversing Chemotherapeutic Drug Resistance in Tumor or Cancer Cells Utitlizing an Acidically-Modified Dominant Negative
US Application 09/414,089
Filed on 1999-10-07

Method for Increasing the Antigen Presenting Ability of Leukemia Cells

  • Read more about Method for Increasing the Antigen Presenting Ability of Leukemia Cells
US Patent 6,358,736
Filed on 1999-09-22

IDENTIFICATION OF INHIBITORS OF THE HGF-MET UPA-PLASMIN NETWORK USING A NOVEL CELLULAR ASSAY

  • Read more about IDENTIFICATION OF INHIBITORS OF THE HGF-MET UPA-PLASMIN NETWORK USING A NOVEL CELLULAR ASSAY
Patent Cooperation Treaty
PCT/US1999/025910
Filed on 1999-11-03

Antigens, Means, and Method for the Diagnosis of Lymphadenopathy and Acquired Immune Deficiency Syndrome

  • Read more about Antigens, Means, and Method for the Diagnosis of Lymphadenopathy and Acquired Immune Deficiency Syndrome
US Application 07/876,297
Filed on 1992-04-30

NUCLEIC ACIDS ENCODING IMMUNOTOXINS CONTAINING A DISULFIDE-STABILIZED ANTIBODY FRAGMENT JOINED TO A PSEUDOMONAS EXOTOXIN THAT DOES NOT...

  • Read more about NUCLEIC ACIDS ENCODING IMMUNOTOXINS CONTAINING A DISULFIDE-STABILIZED ANTIBODY FRAGMENT JOINED TO A PSEUDOMONAS EXOTOXIN THAT DOES NOT...
US Patent 6,074,644
Filed on 1999-09-17

ATP-Binding Transporter (ABC7) and Method for Detection of Anemia and Ataxia

  • Read more about ATP-Binding Transporter (ABC7) and Method for Detection of Anemia and Ataxia
US Patent 6,867,017
Filed on 1999-10-21

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1514
  • Page 1515
  • Page 1516
  • Page 1517
  • Page 1518
  • Page 1519
  • Page 1520
  • Page 1521
  • Page 1522
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health